US Dollar vs Yen

登録してリアルタイムのアラート、カスタムポートフォリオ、市場の動きを入手してください。

ホーム
投資
株式
ドイツ
TG
SynBiotic SE (SBX) 銘柄情報

SynBiotic SE (SBX)

1.60

-0.038

(-2.32%)

終了 6月15日 5:00AM

SynBiotic SE (SBX) 銘柄情報

個人投資家向けのプロ仕様のツール。

プレミアム

通貨

1.60

( -2.32% )

買値

1.572

売値

1.628

出来高

12,985

1.57 日の範囲 1.698

0.00 52 週間の範囲 0.00

時価総額

前日終値

1.638

始値

1.58

時刻

最終取引時間

財務取引量

-

VWAP

-

平均取引量 (3 か月)

100 €

発行済株式数

6,820,000

配当利回り

PER

-1

1 株当たり利益 (EPS)

-2.24

歳入

3.86M

純利益

-10.63M

SynBiotic SE engages in the research and development, production, and marketing of cannabinoid and terpene-based solutions to for pain, sleep deprivation, and anxiety. It also offers hemp, cannabinoids, dietary supplements, and cosmetic products; medical cannabis products; and cannabis products for ... SynBiotic SE engages in the research and development, production, and marketing of cannabinoid and terpene-based solutions to for pain, sleep deprivation, and anxiety. It also offers hemp, cannabinoids, dietary supplements, and cosmetic products; medical cannabis products; and cannabis products for recreational use under the Hempamed, Princess Stardust, The Hempany, and Hempamed Rx brand names. The company was formerly known as Ledgertech SE and changed its name to SynBiotic SE. SynBiotic SE was founded in 2017 and is based in Munich, Germany. 詳細を表示

セクター

Healthcare

業界

Pharmaceuticals

ウェブサイト

www.synbiotic.com

本社

Munich, Germany

設立

2026

SynBiotic SE is listed in the Healthcare sector of the Tradegate (DE) with ticker SBX. The last closing price for SynBiotic was 1.64 €. Over the last year, SynBiotic shares have traded in a share price range of 0.00 € to 0.00 €.

SynBiotic currently has 6,820,000 shares in issue. The market capitalisation of SynBiotic is 10.91 € million. SynBiotic has a price to earnings ratio (PE ratio) of -1.00.

表示するニュースはありません。

期間 †	前日比	前日比 %	始値	高値	安値	平均出来高	VWAP
1	0	0	0	0	0	0	0	DE
4	0	0	0	0	0	0	0	DE
12	0	0	0	0	0	0	0	DE
26	0	0	0	0	0	0	0	DE
52	0	0	0	0	0	0	0	DE
156	0	0	0	0	0	0	0	DE
260	0	0	0	0	0	0	0	DE

SBX - Frequently Asked Questions (FAQ)

What is the current SynBiotic SE share price?

The current share price of SynBiotic SE is 1.60 €

How many SynBiotic SE shares are in issue?

SynBiotic SE has 6,820,000 shares in issue

What is the market cap of SynBiotic SE?

The market capitalisation of SynBiotic SE is EUR 10.91M

What is the 1 year trading range for SynBiotic SE share price?

SynBiotic SE has traded in the range of 0.00 € to 0.00 € during the past year

What is the PE ratio of SynBiotic SE?

The price to earnings ratio of SynBiotic SE is -1

What is the cash to sales ratio of SynBiotic SE?

The cash to sales ratio of SynBiotic SE is 3.94

What is the registered address of SynBiotic SE?

The registered address for SynBiotic SE is Barer Strasse 7, Munich, Bavaria, 80333

What is the SynBiotic SE website address?

The website address for SynBiotic SE is www.synbiotic.com

Which industry sector does SynBiotic SE operate in?

SynBiotic SE operates in the Pharmaceuticals sector

Jonjones325

Jonjones325 6分前

Sorry, you don’t know that either and we all don’t know what was in the sap.

Tadaaa

I would watch the Vid in Sam's Wow. Post, lofty numbers TBD, but the analysis was well done and may answer your question GLTA

MonkRebel181

MonkRebel181 9分前

Alright Csuck, sell at that bid and drop this to .27. When the RSI drops to 10 this week, I’d recommend buying $50,000 worth. Then please sell when the RSI crosses .80 after this earnings run up. Then revisit this again in the October around .18 cents. Load up and sell at the November pump.

Chartmaster

Chartmaster 11分前

Stock futures up sharply, nasdaq up 500, oil down $4, I'm loaded with SPY, XLF, and TQQQ calls, and XLE puts, should be a very bullish 4 day week, oil going to 68-72 now 80.54

satter

satter 12分前

Hiru/Ameerex. These are not new I reported on two of them before here

https://investorshub.advfn.com/boards/read_msg.aspx?message_id=177673228

One was not listed for some reason when I last checked. Its listed now. It's to JP Morgan Chase Bank N.A. It

speakhim

speakhim 16分前

Why do you ask? Smoke and mirrors again ? I'm guessing you think you're right about something and you're trying to keep the topic going to continue your negative gravy train? Must be something coming positive or you wouldn't be kicking a horse you can't see.

k9narc

k9narc 20分前

How did Hamlin get scored with 67 points?

Asking for a very stoned friend.

FOFreddie

FOFreddie 22分前

I held common and JPS when the warrant agreement was executed and I believed it was fair in the midst of the GFC. Knowing what I know now - I believe Paulson and his RINOS set Fannie and Freddie up to fail but no litigation has made it past a dismissal.
Today Fannie and Freddie would not

TightCoil

TightCoil 23分前

URG -
Don't Ignore Genetic Signalling telling you to Load Up -
Be Good to Your Genes, and Your Genes will be Good to You...
Load up if that's what they're tellin' ya to do...

ghostandgurgi

ghostandgurgi 23分前

All of that is correct, and in all that time and all that study there has not been a single commercially reliable net positive amount of energy created. Yet somehow many on here believe that this tiny OTC ticker has stumbled on the way to make fusion work for commercial purposes. If it actually

shurtha2000

shurtha2000 23分前

Mullahs don't make deals

Guido2

Guido2 24分前

Attaching a link to the warrant repurchase offer.

https://home.treasury.gov/news/press-releases/200962612255225533

1973Scoobydoo

1973Scoobydoo 25分前

by the end of the month I'll 2X my money, that is what its all about. Im not an investor, not a shareholder, I'm a greedy money grubbing day-trader that sees a play. in & out baby.

All stock-related comments and opinions expressed here are my own and do not constitute financial advi

Money Management

Money Management 28分前

Telling lies will go so far. Integrity is needed here.Posting false statements to get people to sell. How low will a man go for a dollar bill

mdb1

A speculative BUBBLE could care less. It just wants to buy buy buy buy because it will be higher next week and the week after and the week after that.

mdb1

A speculative BUBBLE could care less. It just wants to buy buy buy buy because it will be higher next week and the week after and the week after that.

flipper44

flipper44 32分前

Marketing approval is good for cancer vaccines.

Pro-Life

Pro-Life 33分前

$AXP.ax $AUNXF secured transformational farm-in to earn up to 25% in Syria’s Block 9 PSC in Palmyride Basin, positioning AXP Energy for early exposure to re-opening Middle East energy sector following sanctions relief & renewed investment interest.

https://x.com/axp_energy/status/2066

wadegarret

wadegarret 34分前

Valumind- I give up, which one ?

Congrats

ddls

In reality Biel PPS is in freeze position. Monday morning trades will show that, and you will look like a howling pump monkey. And psychologically speaking all your Biel BS has zero effect on my Biel position, NONE

Happy trading, see you at .0001

HGiLS

My point of view is that Eliquis will not be sold by elite but by the company that will buy elite. No one knows what will be the market value of Eliquis in 1.2 or 5 years from now because we don’t know if Pfizer will play ball like Purdue or play fair.

The pr says 26 billion let the

Snoopcad105

Snoopcad105 37分前

So on LinkedIn 2 people from Parker Institute for Cancer Immunotherapy will be on the Today show talking about "Breast Cancer Vaccine Latest with Kristen Dahlgren and Dr. Karen Knudsen". That is the same group who held the cancer vaccine breakfast on capital hill a week and a half ago. Time frame

Helter Skelter

Helter Skelter 42分前

"NVIDIA acts as a distributor for QNX" 😂

https://investorshub.advfn.com/uimage/uploads/2026/6/14/sxrjfBB_Nvidia_a_DISTRIBUTOR_lol_061426.png

The THOR 🏆️ QNX Market (Monopolization)

https://investorshub.advfn.com/uimage/uploads/2026/6/4/bzv

ETFS Short SEK Long EUR

First Trust Dow Jones In...

Dexxos Participacoes S.A ON

Electric Royalties

Flexpoint Sensor Systems (EM)

Avricore Health (PK)

Arzneiwerk AG VIDA

WisdomTree Multi Asset I...

Kobrea Exploration

Delayed Upgrade Clock

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約

ADVFN

すでにアカウントをお持ちですか？サインイン

アカウントをお持ちでないですか？登録

登録することで、ADVFN の利用規約を読み、理解し、同意したこと、および私が個人投資家であることを確認します。